Aurinia Pharmaceuticals reports $31.7 million third-quarter net income
AI Summary- Aurinia Pharmaceuticals reported third-quarter net income of $31.7 million.
- Aurinia recorded $83.7 million in quarterly revenue and 23 cents per share.
- Aurinia expects full-year revenue of $325 million to $330 million.